Why Is Provention Biosciences (PRVB) Stock Up 25% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Provention Biosciences shares are trending after reporting earnings. PRVB stock is also up 25% on hopes of FDA approval for teplizumab.

The post Why Is Provention Biosciences (PRVB) Stock Up 25% Today? appeared first on InvestorPlace.

• Buy This $5 Stock BEFORE This Apple Project Goes Live
• The Best $1 Investment You Can Make Today
• Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
• It doesn’t matter if you have $500 or $5 million. Do this now.